CLINICAL_TRIALS
research
· 2025-10-24
Clinical Trial Update: Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure [Phase 3]
Summary
A Phase 3 trial comparing levetiracetam to magnesium sulfate for seizure prevention in severe preeclampsia/eclampsia is planned and not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nebraska Methodist Health System | Conditions: Severe Preeclampsia, Eclampsia Preeclampsia | Phase 3 | Status: NOT_YET_RECRUITING